US Patent Issued to Abbott Diabetes Care on March 18 for "Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof" (California Inventors)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,254,978, issued on March 18, was assigned to Abbott Diabetes Care Inc. (Alameda, Calif.).

"Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof" was invented by Gary Alan Hayter (Oakland, Calif.) and Andrew H. Naegeli (Walnut Creek, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods, devices, and kits are provided for determining a compatibility of one or more devices in an analyte monitoring system."

The patent was filed on Aug. 22, 2023, under Application No. 18/236,520.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect...